Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Apr;92(4):439–451. doi: 10.1111/j.1349-7006.2001.tb01114.x

Enhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases

Jun Wu 1, Takaaki Akaike 1, Kazuyuki Hayashida 1, Tatsuya Okamoto 1, Akira Okuyama 2, Hiroshi Maeda 1,✉
PMCID: PMC5926730  PMID: 11346467

Abstract

Peroxynitrite (ONOO ‐), which is generated from nitric oxide (NO) and superoxide anion (O2‐) under pathological conditions, plays an important role in pathophysiological processes. Activation of matrix metalloproteinases (MMPs) contributes to tumor angiogenesis and metastasis. NO mediates the enhanced vascular permeability and retention (EPR) effect in solid tumors, and ONOO‐ activates proMMP to MMP in vitro. In this study, we examined the role of ONOO‐ in the EPR effect in solid tumors and normal tissues as related to MMP activation. Authentic ONOO‐, at 50 nmol or higher concentrations, induced the enhanced vascular permeability in normal dorsal skin of mice. ONOO‐ scavengers ebselen and uric acid significantly suppressed the EPR effect in mouse sarcoma 180 (S‐180) tumors. Indirect evidence for formation of ONOO‐ in S‐180 and mouse colon adenocarcinoma (C‐38) tumors included strong immunostaining for nitrotyrosine in the tumor tissue, predominantly surrounding the tumor vessels. MMP inhibitor BE16627B (66.6 mg/kg i.v., given 2 tunes) or SI‐27 (10 mg/kg i.p., given 2 times) significantly suppressed the ONOO‐induced EPR effect in S‐180 tumors and in normal skin. Soybean trypsin inhibitor (Kunitz type), broad‐spectrum proteinase inhibitor ovomacroglobulin, and bradykinin receptor antagonist HOE 140 also significantly suppressed the ONOO‐induced EPR effect in normal skin tissues. These data suggest that ONOO‐ may be involved in and promote the EPR effect in tumors, which could be mediated partly through activation of MMPs and a subsequent proteinase cascade to generate potent vasoactive mediators such as bradykinin.

Keywords: Peroxynitrite, Matrix metalloproteinases, Nitric oxide, Bradykinin, Enhanced permeability and retention (EPR) effect

Full Text

The Full Text of this article is available as a PDF (4.3 MB).

References

  • 1.Matsumura , Y. . and Maeda , H.A new concept for macro‐molecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS . Cancer Res. , 46 , 6387 – 6392 ( 1986. ). [PubMed] [Google Scholar]
  • 2.Maeda , H.SMANCS and polymer‐conjugated macromolecular drugs: advantages in cancer chemotherapy . Adv. Drug Delivery Rev. , 6 , 181 – 202 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 3.Maeda , H.Polymer conjugated macromolecular drugs for tumor‐specific targeting . In “ Polymeric Site‐specific Pharmacotherapy ,” ed. Domb A. J. , pp . 96 – 116 ( 1994. ). John Wiley & Sons Ltd. , New York . [Google Scholar]
  • 4.Duncan , R. , Connors , T. A. . and Maeda , H.Drug targeting in cancer therapy: the magic bullet, what next ? J. Drug Targeting , 3 , 317 – 319 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 5.Muggia , F. M.Doxorubicin‐polymer conjugates: further demonstration of the concept of enhanced permeability and retention . Clin. Cancer Res. , 5 , 7 – 8 ( 1991. ). [PubMed] [Google Scholar]
  • 6.Maeda , H. , Matsumura , Y. . and Kato , H.Purification and identification of [hydroxyprolyl3] bradykinin in ascitic fluid from a patient with gastric cancer . J. Biol. Chem. , 263 , 16051 – 16054 ( 1988. ). [PubMed] [Google Scholar]
  • 7.Matsumura , Y. , Kimura , M. , Yamamoto , T. . and Maeda , H.Involvement of the kinin‐generating cascade in enhanced vascular permeability in tumor tissue . Jpn. J. Cancer Res. , Gann , 1327 – 1334 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wu , J. , Akaike , T. . and Maeda , H.Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger . Cancer Res. , 58 , 159 – 165 ( 1998. ). [PubMed] [Google Scholar]
  • 9.Maeda , H. , Noguchi , Y. , Sato , K. . and Akaike , T.Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor . Jpn. J. Cancer Res. , 85 , 331 – 334 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Doi , K. , Akaike , T. , Horie , H. , Noguchi , Y. , Fujii , S. , Beppu , T. , Ogawa , M. . and Maeda , H.Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth . Cancer , 77 , 1598 – 1604 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 11.Senger , D. R. , Galli , S. J. , Dvorak , A. M. , Perruzzi , C. A. , Harvey , V. S. . and Dvorak , H. F.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid . Science , 219 , 983 – 985 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 12.Moncada , S. , Palmer , R. M. J. . and Higgs , E. A.Nitric oxide: physiology, pathophysiology, and pharmacology . Pharmacol. Rev. , 43 , 109 – 137 ( 1991. ). [PubMed] [Google Scholar]
  • 13.Bredt , D. S. . and Snyder , S. H.Nitric oxide: a physiologic messenger molecule . Annu. Rev. Biochem. , 63 , 175 – 195 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 14.Akaike , T. . and Maeda , H.Pathophysiological effects of high‐output production of nitric oxide . In “ Nitric Oxide: Biology and Pathobiology ,” ed. Ignarro L. J. , pp . 733 – 745 ( 2000. ). Academic Press; , San Diego . [Google Scholar]
  • 15.Thomsen , L. L. , Lawton , F. G. , Knowles , R. G. , Beesley , J. E. , Riveros‐Moreno , V. . and Moncada , S.Nitric oxide synthase activity in human gynecological cancer . Cancer Res. , 54 , 1352 – 1354 ( 1994. ). [PubMed] [Google Scholar]
  • 16.Jenkins , D. C. , Charles , I. G. , Thomsen , L. L. , Moss , D. W. , Holmes , L. S. , Baylis , S. A. , Rhodes , P. , Westmore , K. , Emson , P. C. . and Moncada , S.Role of nitric oxide in tumor growth . Proc. Natl. Acad. Sci. USA , 92 , 4392 – 4396 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cobbs , C. S. , Brenman , J. E. , Aldape , K. D. , Bredt , D. S. . and Israel , M. A.Expression of nitric oxide synthase in human central nervous system tumors . Cancer Res. , 55 , 727 – 730 ( 1995. ). [PubMed] [Google Scholar]
  • 18.Ambs , S. , Merriam , W. G. , Bennett , W. P. , Felley‐Bosco , E. , Ogunfusika , M. O. , Oser , S. M. , Klein , S. , Shields , P. G. , Billiar , T. R. . and Harris , C. C.Frequent nitric oxide synthase‐2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression . Cancer Res. , 58 , 334 – 341 ( 1998. ). [PubMed] [Google Scholar]
  • 19.Xiong , M. , Elson , G. , Legarda , D. . and Leibovich , S. J.Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the indueible nitric oxide synthase pathway . Am. J. Pathol. , 153 , 587 – 598 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Miller , R. A. . and Britigan , B. E.The formation and biologic significance of phagocyte‐derived oxidants . J. Invest. Med. , 43 , 39 – 49 ( 1995. ). [PubMed] [Google Scholar]
  • 21.Akaike , T. , Suga , M. . and Maeda , H.Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO . Proc. Soc. Exp. Biol. Med. , 217 , 64 – 73 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 22.Xia , Y. , Dawson , V. L. , Dawson , T. M. , Snyder , S. H. . and Zweier , J. L.Nitric oxide synthase generates superoxide and nitric oxide in arginine‐depleted cells leading to perox‐ynitrite‐mediated cellular injury . Proc. Natl. Acad. Sci. USA , 93 , 6770 – 6774 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Xia , Y. . and Zweier , J. L.Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages . Proc. Natl. Acad. Sci. USA , 94 , 6954 – 6958 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Huie , R. E. . and Padmaja , S.The reaction rate of nitric oxide with superoxide . Free Radic. Res. Commun. , 18 , 195 – 199 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 25.Beckman , J. S. . and Koppenol , W. H.Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly . Am. J. Physiol , 271 , C1424 – C1437 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 26.Himelstein , B. P. , Canete‐Soler , R. , Bernhard , E. J. , Dilks , D. W. . and Muschel , R. J.Metalloproteinases in tumor progression: the contribution of MMP‐9 . Invasion Metastasis , 14 , 246 – 258 ( 199495. ). [PubMed] [Google Scholar]
  • 27.Fang , J. , Shing , Y. , Wiederschain , D. , Yan , L. , Butterfield , C. , Jackson , G. , Harper , J. , Tamvakopoulos , G. . and Moses , M. A.Matrix metalloproteinase‐2 is required for the switch to the angiogenic phenotype in a tumor model . Am. J. Pathol , 97 , 3884 – 3889 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Chambers , A. F. . and Matrisian , L. M.Changing views of the role of matrix metalloproteinases in metastasis . J. Natl. Cancer Inst. , 89 , 1260 – 1270 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 29.Zhu , W. H. , Quo , X. , Villaschi , S. and Francesco Nicosia , R.Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis . Lab. Invest. , 80 , 545 – 555 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 30.Okamoto , T. , Akaike , T. , Nagano , T. , Miyajima , S. , Suga , M. , Ando , M. , Ichimori , K. . and Maeda , H.Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide . Arch. Biochem. Biophys. , 342 , 261 – 274 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 31.Zhu , L. , Gunn , C. . and Beckman , J. S.Bactericidal activity of peroxynitrite . Arch. Biochem. Biophys. , 298 , 452 – 457 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 32.Naito , K. , Kanbayashi , N. , Nakajima , S. , Murai , T. , Arakawa , K. , Nishimura , S. . and Okuyama , A.Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor . Int. J. Cancer , 58 , 730 – 735 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 33.Koike , H. , Tomioka , S. , Sorimachi , H. , Saido , T. C. , Maruyama , K. , Okuyama , A. , Fujisawa‐Sehara , A. , Ohno , S. , Suzuki , K. . and Ishiura , S.Membrane‐anchored metalloprotease MDC9 has an α‐secretase activity responsible for processing the amyloid precursor protein . Biochem. J. , 343 , 371 – 375 ( 1999. ). [PMC free article] [PubMed] [Google Scholar]
  • 34.Okamoto , T. , Akaike , T. , Suga , M. , Tanase , S. , Horie , H. , Miyajima , S. , Ando , M. , Ichinose , Y. . and Maeda , H.Activation of human matrix metalloproteinases by various bacterial proteinases . J. Biol. Chem. , 272 , 6059 – 6066 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 35.Matsumoto , K. , Maeda , H. , Takata , K. , Kamata , R. . and Okamura , R.Purification and characterization of four proteases from clinical isolate of Serratia marcescens kums 3958 . J. Bacterial. , 157 , 225 – 232 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kamata , R. , Yamamoto , T. , Matsumoto , K. . and Maeda , H.A serratial protease causes vascular permeability reaction by activation of the Hageman factor‐dependent pathway in guinea pig . Infect. Immun. , 48 , 747 – 753 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Molla , A. , Yamamoto , T. , Akaike , T. , Miyoshi , S. . and Maeda , H.Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases . J. Biol. Chem. , 264 , 10589 – 10594 ( 1989. ). [PubMed] [Google Scholar]
  • 38.Akaike , T. , Noguchi , Y. , Ijiri , S. , Setoguchi , K. , Suga , M. , Zheng , Y. M. , Dietzschold , B. . and Maeda , H.Pathogenesis of influenza virus‐induced pneumonia: involvement of both nitric oxide and oxygen radicals . Proc. Natl. Acad. Sci. USA , 96 , 2448 – 2453 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Masumoto , H. . and Sies , H.The reaction of ebselen with peroxynitrite . Chem. Res. Toxicol. , 9 , 262 – 267 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 40.Hooper , D. C. , Spitsin , S. , Kean , R. B. , Champion , J. M. , Dickson , G. M. , Chaudhry , I. . and Koprowski , H.Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis . Proc. Natl. Acad. Sci. USA , 95 , 675 – 680 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hock , F. J. , Wirth , K. , Albus , U. , Linz , W. , Gerhards , H. J. , Wiemer , G. , Henke , S. , Breipohl , G. , Konig , W. , Knolle , J. . and Schölkens , B. A.Hoe 140 a new potent and long acting BK‐antagonist: in vitro studies . Br. J. Pharmacol. , 102 , 769 – 773 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wirth , K. , Hock , F. J. , Albus , U. , Linz , W. , Alpermann , H. G. , Anagnostopoulos , H. , Henk , S. , Breipohl , G. , Konig , W. , Knolle , J. . and Schölkens , B. A.Hoe 140 a new potent and long acting BK‐antagonist: in vivo studies Br. J. Pharmacol. , 102 , 774 – 777 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kleiner , D. . and Stetler‐Stevenson , W. G.Quantitative zymography: detection of picogram quantities of gelatinases . Anal. Biochem. , 218 , 325 – 329 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 44.Ohashi , K. , Nemoto , T. , Nakamura , K. . and Nemori , R.Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1‐matrix metalloproteinase in esophageal squamous cell carcinomas . Cancer , 88 , 2201 – 2209 ( 2000. ). [PubMed] [Google Scholar]
  • 45.Sawa , T. , Akaike , T. . and Maeda , H.Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase . J. Biol. Chem. , 275 , 32467 – 32474 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 46.Matsumura , Y. , Maruo , K. , Kimura , M. , Yamamoto , T. , Konno , T. . and Maeda , H.Kinin‐generating cascade in advanced cancer patients and in vitro study . Jpn. J. Cancer Res. , 82 , 732 – 741 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Maeda , H. , Wu , J. , Okamoto , T. , Maruo , K. . and Akaike , T.Kallikrein‐kinin in infection and cancer . Immunopharmacology , 43 , 115 – 128 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 48.Maeda , H. , Wu , J. , Sawa , T. , Matsumura , Y. . and Hori , K.Tumor vascular permeability and EPR effect for macromolecular therapeutics: a review . J. Controlled Release , 65 , 271 – 284 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 49.Noguchi , Y. , Wu , J. , Duncan , R. , Strohalm , J. , Ulbrich , K. , Akaike , T. . and Maeda , H.Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues . Jpn. J. Cancer Res. , 89 , 307 – 314 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Iwai , K. , Maeda , H. . and Konno , T.Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X‐ray image . Cancer Res. , 442115 – 2121 ( 1984. ). [PubMed] [Google Scholar]
  • 51.Konno , T. , Maeda , H. , Iwai , K. , Maki , S. , Tashiro , S. , Uchida , M. . and Miyauchi , Y . Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium . Cancer , 54 , 2367 – 2374 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 52.Seymour , L. W. , Miyamoto , Y. , Maeda , H. , Brereton , M. , Strohalm , J. , Ulbrich , K. . and Duncan , R.Influence of molecular weight on passive tumor accumulation of a soluble macromolecular drug carrier . Eur. J. Cancer , 31 , 766 – 770 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 53.Langer , R.Drug delivery and targeting . Nature , 392 ( Suppl ), 5 – 10 ( 1998. ). [PubMed] [Google Scholar]
  • 54.Ridger , V. C. , Greenacre , S. A. B. , Handy , R. L. C. , Halliwell , B. , Moore , P. K. , Whiteman , M. . and Brain , S. D.Effect of peroxynitrite on plasma extravasation, microvascular blood flow and nociception in the rat . Br. J. Pharmacol. , 122 , 1083 – 1088 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Rosenberg , G. A. , Estrada , E. Y. . and Dencoff , J. E.Matrix metalloproteinases and TIMPs are associated with blood‐brain barrier opening after reperfusion in rat brain . Stroke , 29 , 2189 – 2195 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 56.Frears , E. R. , Zhang , Z. , Blake , D. R. , O'Connell , J. P . and Winyard , P. G.Inactivation of tissue inhibitor of metalloproteinase‐1 by peroxynitrite . FEBS Lett , 381 , 21 – 24 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 57.Nielsen , B. S. , Timshel , S. , Kjeldsen , L. , Sehested , M. , Pyke , C. , Borregaard , N. . and Dano , K.92 kDa type IV collagenase (MMP‐9) is expressed in neutrophils and macro‐phages but not in malignant epithelial cells in human colon cancer . Int. J. Cancer , 65 , 57 – 62 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 58.Doi , K. , Akaike , T. , Fujii , S. , Tanaka , S. , Ikebe , N. , Beppu , T. , Shibahara , S. , Ogawa , M. . and Maeda , H.Induction of haem oxygenase‐1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth . Br. J. Cancer , 80 , 1945 – 1954 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Okamoto , T. , Akaike , T. . and Maeda , H.Activation mechanisms of matrix metalloproteinases Seikagaku , 71 , 1387 – 1401 ( 1999. ). [PubMed] [Google Scholar]
  • 60.Lijnen , H. R. , Ugwu , F. , Bini , A. . and Collen , D.Generation of an angiostatin‐like fragment from plasminogen by stromelysin‐1 (MMP‐3) . Biochemistry , 37 , 4699 – 4702 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 61.Sakata , Y. , Akaike , T. , Suga , M. , Ijiri , S. , Ando , M. . and Maeda , H.Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa . Microbiol. Immunol. , 40 , 415 – 423 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 62.Maruo , K. , Akaike , T. , Ono , T. . and Maeda , H.Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist . Infect. Immun. , 66 , 866 – 869 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES